Funding News

June 5, 2019

NIAID Funding News provides funding, policy, and other information to NIAID's extramural research community and Institute staff. You can subscribe directly by entering your email address at Email Updates and then selecting your subscription topics. Visit Stay Informed About Policy Changes and News for more opportunities to connect with us.

Research and Development

Contracts describe a defined government requirement for a product or service with specific deliverables and deadlines, and work done under a contract requires programmatic guidance by NIAID staff.

Credit: NIH

Take a Closer Look at Contracts

NIAID supports many academic investigators under research and development contracts; learn what contracts are, how they differ from grants, and how to determine whether a solicitation is right for you.

Opportunities and Resources

Small Business Omnibus Grant Opportunities Reissued for 2019

Review NIAID’s scientific topics of interest and budget information for entrepreneurs seeking a small business grant for Phase I or Phase II research.

Want To Be a Lasker Scholar? Here’s Your Chance

The two-phased Program combines a period of research experience as a tenure-track investigator in NIH’s Intramural Research Program (IRP) with additional years of independent financial support either within IRP or at an extramural research institution.

Funding Available To Study HLA and KIR Region Genomics

This initiative focuses on the correlation between sequence variations in the HLA and KIR regions as they pertain to clinical disease phenotype, risk, severity, progression, and response to therapy and transplantation outcomes.

In The News

Don’t Overlook Initiatives for Physician-Scientists, Primary Caregivers

Sometimes we design a funding opportunity announcement to assist a demographic of researchers rather than elicit a specific area of scientific research.

Get on the NExTRAC to Emerging Biotechnology

In an effort to eliminate duplicative review and reporting requirements and to refocus the role of the NIH Recombinant DNA Advisory Committee, NIH issued the Notice of the Publication of Revised NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules.

Advice Corner

New Advice for Investigator-Initiated Clinical Trial Applicants

Far too often, we’ve seen applicants underestimate the time, cost, or regulatory requirements of clinical trials. This can lead to award delays while you revise your plans.

Reader Questions

“Should I include intellectual property in my application?”


“Is the renewal cap applied only to the first year of a renewal budget or to all the other years as well?”


Browse all Articles